The moon's very different sides explained in new NASA study
Scientists have discovered key differences under the moon's surface that may explain why its two hemispheres look so different.
The moon's near side, the side visible to Earth, is dark and covered in the remnants of ancient lava flows.
Its far side, which we can't see from Earth, is rugged and rocky.
Scientists have long suspected the differences could be explained by what's inside the moon but until now, couldn't prove it.
"We found that the moon's near side is flexing more than the far side, meaning there's something fundamentally different about the internal structure of the moon's near side compared to its far side," said Ryan Park, who led the team from NASA's Jet Propulsion Laboratory.
"When we first analysed the data, we were so surprised by the result we didn't believe it. So we ran the calculations many times to verify the findings.
"In all, this is a decade of work."
The team studied data gathered by the Gravity Recovery and Interior Laboratory (GRAIL) mission.
For that mission, two spacecraft, Ebb and Flow, were sent to orbit the moon for a year between 2011 and 2012.
They used that data to map how the moon responds to Earth's gravitational pull as it orbits.
The moon's gravity slightly fluctuates as it circles the Earth which causes it to flex.
That movement helped the scientists to understand the moon's deep internal structure and discovered that the moon's near side is internally warmer than its far side.
Although this helps with crucial understanding of the moon, it may also help us understand other planets.
In fact, the team have already used their technique to map the internal structures of planets like Jupiter and the Vesta asteroid.
"There are many opportunities in the future to apply our technique for studying the interiors of intriguing planetary bodies throughout the solar system," said Mr Park.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
11 minutes ago
- Reuters
Experts doubt FBI's claim that crop fungus smuggled by Chinese students is a threat
CHICAGO, June 6 (Reuters) - A biological sample that a Chinese researcher was accused of smuggling into the United States and that prosecutors cast as a "dangerous biological pathogen" is a common type of fungus already widespread in U.S. crop fields that likely poses little risk to food safety, experts said. On Tuesday, U.S. federal prosecutors, opens new tab accused two Chinese researchers of smuggling samples of the fungus Fusarium graminearum into the U.S., describing it as a potential agricultural terrorism weapon. Yunqing Jian, 33, a researcher at the University of Michigan's Department of Molecular, Cellular and Developmental Biology has been charged in connection with allegations that she helped her boyfriend, Zunyong Liu, 34, smuggle the pathogen into the U.S. However, agriculture experts interviewed by Reuters this week said the fungus has been in the U.S. for more than a century, can be prevented by spraying pesticides, and is only dangerous if ingested regularly and in large quantities. "As a weapon, it would be a pretty ineffective one," said Jessica Rutkoski, a crop sciences professor, wheat breeder and geneticist at the University of Illinois at Urbana-Champaign. Rutkoski and other researchers said extensive testing for the fungus' toxin, widespread use of fungicides and the difficulty of intentionally creating an infection with the pathogen would make it a clumsy weapon. The U.S. Attorney's Office and the FBI declined Reuters' request for comment. Since the 1900s, U.S. farmers have been battling the fungus, which causes Fusarium head blight, usually known as "scab," which often infects wheat, barley and other grains on farms during rainy years. The telltale pink streaks on the grain heads contain a toxic byproduct called vomitoxin, which is tested for and tightly controlled by grain elevators where farmers sell their crops. Constant testing and monitoring means that only negligible amounts of vomitoxin ever make it into the bread, pasta and cookies Americans eat, far below levels that would sicken a human, experts said. "We have a long history of managing epidemics of scab," said Andrew Friskop, professor and plant pathologist at North Dakota State University, noting that farmers have access to many tools to prevent and control the disease. Farmers began regularly spraying their fields with fungicide as early as the 1990s, and researchers have since developed multiple strains of fungus-resistant wheat. Plant experts said that it would be difficult to fully assess the risks posed by the samples without more information on the particular strain. But Rutkoski, whose research involves intentionally contaminating wheat with the fungus, said that she isn't always successful at infecting her test field's wheat with scab. She said the pathogen is difficult to control, and her lab has to strike the right balance of temperature and humidity to create an infection. In federal court in Detroit on Tuesday, Jian was charged with conspiracy to commit offense or to defraud the U.S., smuggling goods into the U.S., false statements and visa fraud. Jian did not comment on the charges, and the lawyer who represented her in court was not immediately available for comment. Liu could not be immediately reached for comment. The court scheduled Jian's bail hearing for June 13.
Daily Mail
2 hours ago
- Daily Mail
Subtle warning signs of 'silent disease' 16m Americans are living with and don't know
Nearly 16 million people have the most deadly type of liver disease, yet 80 percent of them have no idea. About five percent of adults worldwide have metabolic dysfunction-associated steatohepatitis (MASH) a serious liver condition caused by fat buildup, inflammation, and scarring. It's the most dangerous type of fatty liver disease MASH triggers liver scarring, which can progress to cirrhosis, and significantly increases the risk of heart disease, chronic kidney disease, and liver cancer. Just one in five Americans with the condition are actually diagnosed. Most patients do not experience symptoms until the damage is irreversible, making it a 'silent disease'. However, as the condition progresses, individuals may experience fatigue, pain or discomfort in the upper right belly, unexplained weight loss, weakness, and in some cases, jaundice (yellowing of the skin and eyes). A coalition of researchers from the US, Europe, and South Africa said that MASH-related liver failure and other complications, including deaths, are becoming more severe and common. The scientists behind the report, published in The Lancet Regional Health Europe, are calling for a doubling in MASH diagnosis rates from the 2022 level, about 13 percent (the current rate is just under 20 percent). They estimated that about 2.6 million people in the US, UK, Germany, and France have been diagnosed with MASH. But if testing were adequately improved and scaled up to become more accessible and commonplace, that figure could balloon to 6.1 million. People with type 2 diabetes, obesity, and heart disease should be prioritized for blood work and other screening tests, which will need to skyrocket from about two million to 36 million. Follow-up testing also needs to jump by nearly 1,300 percent to meet patient needs, and in more settings than liver clinics, such as family doctors' offices, and with diabetes and heart doctors. People with diabetes are especially prone to liver damage leading to MASH. Around 30 to 60 percent of diabetics also have MASH. Obesity is another leading risk factor, with estimates suggesting that 75 percent of overweight people and 90 percent with obesity will develop the condition. People with MASH also have a tripled risk of also developing heart disease, including coronary artery disease, stroke, and heart failure, compared to people without the condition. MASH diagnosis is poised for a major shift, mirroring past breakthroughs in chronic disease management. With new treatments approved and others on the horizon, the focus now turns to fixing systemic roadblocks. Currently, limited access to non-invasive tests and reliance on specialists leave most cases undetected until late stages. MASH arises from a cascade of liver damage typically linked to a buildup of fat in the liver, which triggers inflammation that damages liver cells and activates scar-forming cells. What was once healthy liver tissue becomes stiff, progressively crippling the liver's ability to detoxify blood. Though this is often painless until the damage becomes too severe to be reversed. If caught early, people can live normal lifespans with MASH. Lifestyle changes - eating a healthier diet, exercising regularly, and losing between five and 10 percent of one's body weight - can slow down the progression of MASH and repair some of the damage. Doctors may prescribe resmetirom, the first FDA-approved medication for MASH, to work hand-in-hand with those lifestyle changes. But severe damage can cause deadly conditions that cut a person's life drastically short. 'Each late-stage MASH diagnosis represents a missed opportunity for earlier intervention to prevent disease progression, threatening worse [liver] and [non-liver] outcomes for people living with the condition and greater costs for individuals, health systems, and societies,' researchers told a Barcelona medical conference this week. The solution requires concrete changes from moving diagnostics to implementing automated tools in electronic records. The researchers said that success in improving diagnostics goes beyond devising better tests. A fundamental reworking of methods of care is needed that catches at-risk patients before irreversible damage occurs. 'Paradigm shifts do not occur in a vacuum, but arise when leaps in science, technology, and innovation are coupled with changes in perception and understanding within a community,' they said. 'A confluence of factors in 2024 and expected drug approvals in many European countries in 2025 point to a near term tipping point for MASH diagnoses; nonetheless, focused and sustained efforts are needed to turn such opportunities into reality.'
The Sun
2 hours ago
- The Sun
At-home ‘brain quiz' reveals your risk of heart disease, stroke, dementia and 3 types of cancer
AN at-home 'brain quiz' can reveal your risk of dementia, as well stroke, heart disease and three common types of cancer. It suggests that taking better care of your brain could boost your overall health, researchers said. Developed at Mass General Brigham - a hospital affiliated with Harvard Medical School - the McCance Brain Care Score (BCS) is a tool designed to assess modifiable risk factors that influence brain health. The quiz's 21 questions evaluate someone's physical health, lifestyle, as well as social and emotional factors. All together, these can pain a picture of someone's risk of brain diseases that come on with age. But researchers found the quiz could also shed light someone's risk of non-brain related diseases, such as heart disease or cancer. That's because neurological diseases such as stroke, dementia, and late-life depression, as well as cardiovascular diseases —including ischaemic heart disease, stroke, and heart failure —and cancers are often driven by the same risk factors. These include things like unhealthy diet, lack of exercise, smoking, excessive drinking, high blood pressure, cholesterol and blood sugar. Psycho-social factors like stress and social isolation are also drivers of disease. In fact, at least 80 per cent of cardiovascular disease cases and 50 per cent of cancer cases can be linked to these factors, researchers claimed. Senior author Sanjula Singh, of the McCance Center for Brain Health at Massachusetts General Hospital, said: "While the McCance Brain Care Score was originally developed to address modifiable risk factors for brain diseases, we have also found it's associated with the incidence of cardiovascular disease and common cancers." 'These findings reinforce the idea that brain disease, heart disease, and cancer share common risk factors and that by taking better care of your brain, you may also be supporting the health of your heart and body as a whole simultaneously.' 10 second one leg stand test The quiz will generate a score of 0 to 21 - the higher your score, the more brain-healthy habits you practice. Researchers used data from the UK Biobank to analyse health outcomes in 416,370 people aged 40 to 69 years using the test. They found that a 5-point higher BCS score at baseline was associated with a 43 per cent lower risk of developing cardiovascular disease - including ischaemic heart disease, stroke, and heart failure - over 12 and a half years. For cancer, a 5-point increase in BCS was associated with a 31 per cent lower rate of lung, bowel and breast cancer. How to do the quiz Before you take the test, you'll need some information from your health records, such as your latest blood pressure reading, you haemoglobin A1c score, your cholesterol levels and BMI. The test - available on the Mass General Brigham website - starts off by asking people about their blood pressure, cholesterol levels and BMI, as well as smoking, exercise and sleep habits. It also asks patients about social relationships - whether they're close to anyone outside of spouses and children - and if they feel that their "life has meaning". Once you've answered the questions, the quiz will generate a score between 0 and 21, and ways to improve your brain health. The aim is to achieve the highest score possible. The score will be made up of three categories – physical, lifestyle, and social-emotional health – and it measures what you are already doing to protect your brain and prolong your brain health. This can include exercise, sleep, social interactions, lowering blood pressure and more. "Your McCance Brian Care score is a tool you can use to measure and improve how well you care for your brain throughout your life," according to Mass General Brigham. "Small adjustments, like finding some time to walk more in your day or making it a priority to call your best friend, can have a major improvement on your overall score and brain health over time. "Achieving your highest score and keeping your highest score month after month, year after year, will ensure you are taking the best care of your brain as you grow and thrive." Study authors said that previous research suggests that some individual components of the BCS quiz - such as smoking, lack of exercise and high blood pressure - can raise the risk of dementia or heart disease. But they said that their study can't prove that the BSC components can cause disease - only that they are strongly linked. Researchers also noted that the quiz can't be used to predict whether someone will get a specific disease. Instead, it can serve as a framework to help people identify achievable lifestyle changes that support the health of their brain, as well as the rest of their body. Lead author Jasper Senff said: 'The goal of the McCance Brain Care Score is to empower individuals to take small, meaningful steps toward better brain health. 'Taking better care of your brain by making progress on your Brain Care Score may also be linked to broader health benefits, including a lower likelihood of heart disease and cancer. 'Primary care providers around the world are under growing pressure to manage complex health needs within limited time," he went on. 'A simple, easy-to-use tool like the McCance Brain Care Score holds enormous promise - not only for supporting brain health, but also for helping to address modifiable risk factors for a broader range of chronic diseases in a practical, time-efficient way.'
